News

13/10/2025

Nanoligent, a Spin-Off from IR Sant Pau and UAB, Raises €12 Million to Bring a CXCR4-Targeted Nanodrug to the Clinic

Nanoligent, a spin-off from the Institut de Recerca Sant Pau (IR Sant Pau) and the Universitat Autnoma de Barcelona (UAB), has closed a €12 million funding round led by Inveready to advance the deve...

08/10/2025

Dr. Íñigo Rodríguez Baz Receives Alzheimer’s Association Grant to Advance Dementia Diagnosis

Dr. Íñigo Rodríguez Baz, from the Neurobiology of Dementias Group at the Sant Pau Research Institute and the Memory Unit at Hospital Sant Pau, has been awarded a grant from the Alzheimer’s Associ...

07/10/2025

Sant Pau Participates in an International Gene Therapy Trial for Wet Macular Degeneration

The Ophthalmology Department of Hospital de Sant Pau, together with the Ophthalmology Research Group of the Sant Pau Research Institute (IR Sant Pau), has recently participated in an international cli...

06/10/2025

ACE Makes a New Donation to the Sant Pau Research Institute to Support CADASIL Research

The Sant Pau Research Institute (IR Sant Pau) and the CADASIL Spain Association (ACE) have strengthened their collaboration with a new contribution of 15,000 euros. This is aimed at advancing the rese...

01/10/2025

Qdenga Vaccine Shows Effectiveness Against Dengue Under Real-World Conditions During Brazil’s 2024 Outbreak

An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions during the major 2024 e...